This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
L02BG
1 out of 7 registries used, show all original rules.
9407
Check minimum number of events
Min. number of events
3
9407
Include endpoints None
9407
Remove individuals based on genotype QC
9152
RX_L02BG
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF3
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
L02BG Aromatase inhibitors
based on the number of shared cases.
Broader endpoints:
- Medicines for HER+ breast cancer
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 9152 | 9059 | 93 |
| Unadjusted prevalence (%) | 2.22 | 3.93 | 0.05 |
| Mean age at first event (years) | 63.34 | 63.53 | 45.20 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: RX_L02BG – L02BG Aromatase inhibitors
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after L02BG Aromatase inhibitors
↥Endpoint not on priority list, no data to show.